5-HT2 antagonists (Daiichi)

N/A

Report date: 2025/01/26 19:03:01
NME

Base Information

Drug Name5-HT2 antagonists (Daiichi)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsHypertensionCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A